Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) is a publicly traded Healthcare sector company. As of September 14, 2026, RYTM trades at $104.75 with a market cap of $7.21B and a P/E ratio of -33.69. RYTM moved +0.04% today. Year to date, RYTM is -1.92%; over the trailing twelve months it is +6.93%. Its 52-week range spans $45.91 to $122.20. Analyst consensus is strong buy with an average price target of $141.06. Rallies surfaces RYTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks RYTM insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $104.75 |
| Market Cap | $7.21B |
| P/E Ratio | -33.69 |
| EPS | $-3.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $122.20 |
| 52-Week Low | $45.91 |
| Volume | 2.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $239.92M |
| Net Income | $-205.35M |
| Gross Margin | 89.00% |
16 analysts cover RYTM: 0 strong buy, 15 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $141.06.